Emerging Drug-Resistant Bacteria in Ukraine War Victims: A Public Health Crisis
Researchers from Lund University in Sweden discovered total antibiotic resistance in some bacteria found in victims of the Ukraine war. Their latest study in the Journal of Infection examines the infectious nature of these bacteria.
The lead author highlighted the bacterium Klebsiella pneumoniae, which is resistant to all antibiotics and poses a serious threat due to its aggressive nature. The researchers analyzed samples from 141 injured individuals, including adults and newborns with pneumonia. They found various antibiotic-resistant bacteria, with six percent being resistant to all tested antibiotics.
The presence of drug-resistant Klebsiella pneumoniae in Ukraine raises global health concerns, as this strain is responsible for one in five deaths due to antimicrobial resistance (AMR). Klebsiella pneumoniae can lead to several infections, including urinary tract infections, pneumonia, and sepsis.
Kristian Riesbeck, a professor at Lund University, stated that many of the bacteria carry resistance genes, with one-quarter showing total resistance, making treatment difficult or impossible. The team researched the bacteria’s ability to spread using mice and insect larvae. They discovered that the most resistant bacteria thrived better in mice and killed insect larvae faster than less resistant strains.
Interview with Professor Kristian Riesbeck on Total Antibiotic Resistance in Ukraine War Victims
news Directory 3: Thank you for joining us, Professor Riesbeck. Your recent study from Lund university reveals concerning findings regarding antibiotic resistance in bacteria found in Ukrainian war victims. Can you elaborate on the significance of your research?
Professor Kristian Riesbeck: Thank you for having me. Our study sheds light on an alarming public health crisis: the presence of total antibiotic resistance in Klebsiella pneumoniae, a bacterium that has been found in patients who suffered injuries during the war in Ukraine. This strain is particularly dangerous because it is resistant to all known antibiotics, which severely limits treatment options and increases the risk of severe infections.
News Directory 3: Your research involved analyzing samples from 141 patients. What were your main findings regarding antibiotic resistance?
Professor Riesbeck: We discovered that approximately six percent of the bacteria isolated from these patients were fully resistant to all tested antibiotics. This includes a meaningful number of klebsiella pneumoniae strains. the presence of these highly resistant bacteria poses a serious threat not only to the affected individuals but potentially sets the stage for broader outbreaks.
News Directory 3: Can you explain why Klebsiella pneumoniae is particularly concerning in the context of antimicrobial resistance (AMR)?
Professor Riesbeck: Klebsiella pneumoniae is responsible for one in five deaths linked to AMR. It can cause a range of infections, such as urinary tract infections, pneumonia, and sepsis. The bacteria we studied not only demonstrated total resistance but also retained their virulence, which is unusual. While some resistant strains lose pathogenicity, these bacteria possess both the resistance and the capability to cause serious disease, amplifying the public health risk.
News Directory 3: You mentioned that a quarter of the bacteria carry resistance genes.How does this impact treatment options for infected individuals?
Professor Riesbeck: The presence of resistance genes complicates treatment immensely. With one-fourth of the strains showing total resistance, medical professionals face near-impossible challenges. Infections caused by these bacteria may require alternative treatments or, in certain specific cases, become life-threatening due to the lack of effective antibiotics.
news Directory 3: Your study also looked at how these bacteria spread.What were your findings regarding their transmissibility?
Professor Riesbeck: We conducted experiments using mice and insect larvae and found that the most resistant strains thrived better in mice and outpaced less resistant strains in terms of killing insect larvae. This indicates that not only are these bacteria robust and fatal, but they also have a heightened ability to spread, posing risks both in hospital settings and potentially in community environments.
News Directory 3: What measures do you believe need to be taken to mitigate this threat?
Professor Riesbeck: Urgent action is required. Effective patient isolation procedures, strict infection control measures in healthcare facilities, and vigilant antimicrobial stewardship are critical. These bacteria won’t simply disappear; without rigorous management protocols, we risk broader outbreaks that can affect populations beyond Ukraine.
News Directory 3: Given the situation, what do you foresee for global health if this issue is not addressed?
Professor Kristian Riesbeck: The prognosis is grim. These resistant strains carry complete sets of disease-causing genes, ensuring that they can inflict significant harm. If we don’t tackle antimicrobial resistance proactively, we may face a future where routine infections could again become life-threatening. Continued research and global collaboration will be essential to combat this growing threat.
News Directory 3: Thank you for your insights,Professor Riesbeck. Your expertise highlights a critical issue we must address to safeguard public health.
Professor Kristian Riesbeck: Thank you for bringing attention to this significant matter.
The study confirmed that all Klebsiella strains with total resistance also have genes that enhance their virulence. Often, bacteria that rely heavily on resistance lose virulence. However, the bacteria from Ukraine show both resistance and the ability to cause disease, raising alarm for future outbreaks.
Riesbeck warned that these bacteria are unlikely to disappear and that without proper patient isolation and treatment, the infection could spread further. He noted that even amid antibiotic resistance, these bacteria carry complete sets of disease-causing genes, presenting a grim prognosis for global health.
